HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study.

AbstractOBJECTIVE:
We investigated the association between circulating biomarkers of inflammation and MRI markers of small vessel disease.
METHODS:
We performed a cross-sectional study relating a panel of 15 biomarkers, representing systemic inflammation (high-sensitivity C-reactive protein, interleukin-6, monocyte chemotactic protein-1, tumor necrosis factor α, tumor necrosis factor receptor 2, osteoprotegerin, and fibrinogen), vascular inflammation (intercellular adhesion molecule 1, CD40 ligand, P-selectin, lipoprotein-associated phospholipase A2 mass and activity, total homocysteine, and vascular endothelial growth factor), and oxidative stress (myeloperoxidase) to ischemic (white matter hyperintensities/silent cerebral infarcts) and hemorrhagic (cerebral microbleeds) markers of cerebral small vessel disease (CSVD) on MRI in 1,763 stroke-free Framingham offspring (mean age 60.2 ± 9.1 years, 53.7% women).
RESULTS:
We observed higher levels of circulating tumor necrosis factor receptor 2 and myeloperoxidase in the presence of cerebral microbleed (odds ratio [OR] 2.2, 95% confidence interval [CI] 1.1-4.1 and OR 1.5, 95% CI 1.1-2.0, respectively), higher levels of osteoprotegerin (OR 1.1, 95% CI 1.0-1.2), intercellular adhesion molecule 1 (OR 1.7, 95% CI 1.1-2.5), and lipoprotein-associated phospholipase A2 mass (OR 1.5, 95% CI 1.1-2.1), and lower myeloperoxidase (OR 0.8, 95% CI 0.7-1.0) in participants with greater white matter hyperintensity volumes and silent cerebral infarcts.
CONCLUSIONS:
Our study supports a possible role for inflammation in the pathogenesis of CSVD, but suggests that differing inflammatory pathways may underlie ischemic and hemorrhagic subtypes. If validated in other samples, these biomarkers may improve stroke risk prognostication and point to novel therapeutic targets to combat CSVD.
AuthorsAshkan Shoamanesh, Sarah R Preis, Alexa S Beiser, Ramachandran S Vasan, Emelia J Benjamin, Carlos S Kase, Philip A Wolf, Charles DeCarli, Jose R Romero, Sudha Seshadri
JournalNeurology (Neurology) Vol. 84 Issue 8 Pg. 825-32 (Feb 24 2015) ISSN: 1526-632X [Electronic] United States
PMID25632086 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2015 American Academy of Neurology.
Chemical References
  • Biomarkers
  • Inflammation Mediators
Topics
  • Aged
  • Biomarkers (blood)
  • Cerebral Hemorrhage (blood, diagnosis, epidemiology)
  • Cerebral Small Vessel Diseases (blood, diagnosis, epidemiology)
  • Cross-Sectional Studies
  • Female
  • Humans
  • Inflammation Mediators (blood)
  • Male
  • Massachusetts (epidemiology)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: